As we stand at the threshold of 2026, the Year of the Horse, all of us at Synlotic Biotech extend our warmest New Year greetings to you. The horse symbolizes energy, vitality, and an unwavering journey toward success—precisely the spirit we wish for you in the coming year. May 2026 bring you a pasture of fresh opportunities, robust growth, and the strength to achieve all your ambitious goals.
Is your skin feeling dry, sensitive, or lacking its natural resilience? The secret to restoring its healthy glow may lie in reinforcing its most fundamental defense: the skin barrier. At Synlotc Biotech, we harness the power of synthetic biology to masterfully produce high-purity, sustainable Ceramide NP and Ceramide AP, your premier ingredients for next-generation skincare and haircare formulations.
The foundation of ageless skin lies in targeted cellular care. Our curated portfolio of advanced actives is designed to address every key sign of aging—from wrinkles and loss of firmness to hyperpigmentation and barrier degradation.
In the world of skincare, the terms “soothing” and “repairing” are often used interchangeably, but they represent fundamentally different biological processes and skincare objectives. For brands and formulators, understanding this distinction is essential to creating effective products that meet specific consumer needs. At Synlotic Biotech, a Shanghai-based leader in advanced skincare ingredients, we specialize in developing targeted solutions for both pathways.
Synlotic Biotech, a leading innovator in biotech-driven cosmetic ingredients, successfully participated in the PCT 2025 Personal Care Technology Summit & Exhibition held in Guangzhou from November 19 to 20.
From November 4-6, 2025, Synlotic Biotech made a significant impact at the in-cosmetics Asia exhibition in Bangkok. The company successfully showcased its portfolio of high-efficacy cosmetic ingredients powered by proprietary synthetic biology technology.
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies.
Privacy Policy